MX2011009205A - Proteinas de fusion de transcriptasa inversa estabilizada. - Google Patents

Proteinas de fusion de transcriptasa inversa estabilizada.

Info

Publication number
MX2011009205A
MX2011009205A MX2011009205A MX2011009205A MX2011009205A MX 2011009205 A MX2011009205 A MX 2011009205A MX 2011009205 A MX2011009205 A MX 2011009205A MX 2011009205 A MX2011009205 A MX 2011009205A MX 2011009205 A MX2011009205 A MX 2011009205A
Authority
MX
Mexico
Prior art keywords
reverse transcriptase
fusion proteins
protein
stabilized
stabilized reverse
Prior art date
Application number
MX2011009205A
Other languages
English (en)
Spanish (es)
Inventor
Alan M Lambowitz
Sabine Mohr
Georg Mohr
Eman Ghanem
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas filed Critical Univ Texas
Publication of MX2011009205A publication Critical patent/MX2011009205A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241Nucleotidyltransferases (2.7.7)
    • C12N9/1276RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
    • C12P19/28N-glycosides
    • C12P19/30Nucleotides
    • C12P19/34Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y207/00Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/07Nucleotidyltransferases (2.7.7)
    • C12Y207/07049RNA-directed DNA polymerase (2.7.7.49), i.e. telomerase or reverse-transcriptase
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/20Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/24Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a MBP (maltose binding protein)-tag

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
MX2011009205A 2009-03-04 2010-03-04 Proteinas de fusion de transcriptasa inversa estabilizada. MX2011009205A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15733209P 2009-03-04 2009-03-04
PCT/US2010/026165 WO2010102085A2 (en) 2009-03-04 2010-03-04 Stabilized reverse transcriptase fusion proteins

Publications (1)

Publication Number Publication Date
MX2011009205A true MX2011009205A (es) 2011-09-30

Family

ID=42710216

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011009205A MX2011009205A (es) 2009-03-04 2010-03-04 Proteinas de fusion de transcriptasa inversa estabilizada.

Country Status (11)

Country Link
US (4) US10113156B2 (enExample)
EP (2) EP2403941B1 (enExample)
JP (2) JP5882064B2 (enExample)
CN (1) CN102421791A (enExample)
AU (1) AU2010221284B2 (enExample)
BR (1) BRPI1009221A2 (enExample)
CA (1) CA2754476A1 (enExample)
IL (1) IL214913A (enExample)
MX (1) MX2011009205A (enExample)
WO (1) WO2010102085A2 (enExample)
ZA (1) ZA201107207B (enExample)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101818126B1 (ko) * 2011-02-09 2018-01-15 (주)바이오니아 열안정성이 증가된 역전사효소
JP6068365B2 (ja) * 2011-02-23 2017-01-25 ボード・オブ・リージエンツ,ザ・ユニバーシテイ・オブ・テキサス・システム Dna合成のためのテンプレートスイッチの使用
US9340799B2 (en) 2013-09-06 2016-05-17 President And Fellows Of Harvard College MRNA-sensing switchable gRNAs
US9388430B2 (en) 2013-09-06 2016-07-12 President And Fellows Of Harvard College Cas9-recombinase fusion proteins and uses thereof
SG10202104041PA (en) 2015-10-23 2021-06-29 Harvard College Nucleobase editors and uses thereof
US10364420B2 (en) 2015-12-07 2019-07-30 Bio-Rad Laboratories, Inc Dimeric reverse transcriptase
KR20250103795A (ko) 2016-08-03 2025-07-07 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 아데노신 핵염기 편집제 및 그의 용도
US11661590B2 (en) 2016-08-09 2023-05-30 President And Fellows Of Harvard College Programmable CAS9-recombinase fusion proteins and uses thereof
WO2018039438A1 (en) 2016-08-24 2018-03-01 President And Fellows Of Harvard College Incorporation of unnatural amino acids into proteins using base editing
SG11201903089RA (en) 2016-10-14 2019-05-30 Harvard College Aav delivery of nucleobase editors
WO2018119359A1 (en) 2016-12-23 2018-06-28 President And Fellows Of Harvard College Editing of ccr5 receptor gene to protect against hiv infection
US11898179B2 (en) 2017-03-09 2024-02-13 President And Fellows Of Harvard College Suppression of pain by gene editing
EP3592381A1 (en) 2017-03-09 2020-01-15 President and Fellows of Harvard College Cancer vaccine
WO2018165629A1 (en) 2017-03-10 2018-09-13 President And Fellows Of Harvard College Cytosine to guanine base editor
WO2018176009A1 (en) 2017-03-23 2018-09-27 President And Fellows Of Harvard College Nucleobase editors comprising nucleic acid programmable dna binding proteins
WO2018209320A1 (en) 2017-05-12 2018-11-15 President And Fellows Of Harvard College Aptazyme-embedded guide rnas for use with crispr-cas9 in genome editing and transcriptional activation
CN111801345A (zh) 2017-07-28 2020-10-20 哈佛大学的校长及成员们 使用噬菌体辅助连续进化(pace)的进化碱基编辑器的方法和组合物
EP3676376B1 (en) 2017-08-30 2025-01-15 President and Fellows of Harvard College High efficiency base editors comprising gam
US11352611B2 (en) 2017-10-03 2022-06-07 Board Of Regents, The University Of Texas System Non-LTR-retroelement reverse transcriptase and uses thereof
US11795443B2 (en) 2017-10-16 2023-10-24 The Broad Institute, Inc. Uses of adenosine base editors
WO2019118949A1 (en) 2017-12-15 2019-06-20 The Broad Institute, Inc. Systems and methods for predicting repair outcomes in genetic engineering
US12157760B2 (en) 2018-05-23 2024-12-03 The Broad Institute, Inc. Base editors and uses thereof
EP3820495A4 (en) 2018-07-09 2022-07-20 The Broad Institute Inc. RNA-PROGRAMMABLE EPIGENETIC RNA MODIFIERS AND THEIR USES
WO2020092453A1 (en) 2018-10-29 2020-05-07 The Broad Institute, Inc. Nucleobase editors comprising geocas9 and uses thereof
US12351837B2 (en) 2019-01-23 2025-07-08 The Broad Institute, Inc. Supernegatively charged proteins and uses thereof
EP3942043A2 (en) 2019-03-19 2022-01-26 The Broad Institute, Inc. Methods and compositions for editing nucleotide sequences
WO2020214842A1 (en) 2019-04-17 2020-10-22 The Broad Institute, Inc. Adenine base editors with reduced off-target effects
CN114258398A (zh) 2019-06-13 2022-03-29 总医院公司 工程化的人内源性病毒样颗粒及使用其递送至细胞的方法
US12435330B2 (en) 2019-10-10 2025-10-07 The Broad Institute, Inc. Methods and compositions for prime editing RNA
US20230072235A1 (en) * 2020-02-17 2023-03-09 Leadxpro Ag Pro-macrobodies for the enhancement of structure research
EP4114937A4 (en) 2020-03-04 2024-09-04 Flagship Pioneering Innovations VI, LLC METHODS AND COMPOSITIONS FOR MODULATING A GENOME
BR112022022603A2 (pt) 2020-05-08 2023-01-17 Broad Inst Inc Métodos e composições para edição simultânea de ambas as fitas de sequência alvo de nucleotídeos de fita dupla
CN116670154A (zh) 2020-07-24 2023-08-29 总医院公司 增强的病毒样颗粒及使用其递送至细胞的方法
JP2023543803A (ja) 2020-09-24 2023-10-18 ザ ブロード インスティテュート,インコーポレーテッド プライム編集ガイドrna、その組成物、及びその使用方法
EP4274894A2 (en) 2021-01-11 2023-11-15 The Broad Institute, Inc. Prime editor variants, constructs, and methods for enhancing prime editing efficiency and precision
JP2024530487A (ja) 2021-08-06 2024-08-21 ザ ブロード インスティテュート,インコーポレーテッド 改善されたプライムエディターおよび使用方法
EP4707407A3 (en) * 2021-08-17 2026-05-20 New England Biolabs Inc REVERSE TRANSCRIPTION BY CIRCULAR ROLLING CIRCLE OF RNA
KR20260037664A (ko) 2021-09-08 2026-03-18 플래그쉽 파이어니어링 이노베이션스 브이아이, 엘엘씨 게놈을 조절하기 위한 방법 및 조성물
WO2023076898A1 (en) 2021-10-25 2023-05-04 The Broad Institute, Inc. Methods and compositions for editing a genome with prime editing and a recombinase
US20250064979A1 (en) 2021-12-03 2025-02-27 The Broad Institute, Inc. Self-assembling virus-like particles for delivery of prime editors and methods of making and using same
WO2023205687A1 (en) 2022-04-20 2023-10-26 The Broad Institute, Inc. Improved prime editing methods and compositions
WO2023240137A1 (en) 2022-06-08 2023-12-14 The Board Institute, Inc. Evolved cas14a1 variants, compositions, and methods of making and using same in genome editing
WO2024077267A1 (en) 2022-10-07 2024-04-11 The Broad Institute, Inc. Prime editing methods and compositions for treating triplet repeat disorders
EP4619515A1 (en) 2022-11-17 2025-09-24 The Broad Institute, Inc. Prime editor delivery by aav
WO2024168147A2 (en) 2023-02-09 2024-08-15 The Broad Institute, Inc. Evolved recombinases for editing a genome in combination with prime editing
WO2024206125A1 (en) 2023-03-24 2024-10-03 The Broad Institute, Inc. Use of prime editing for treating sickle cell disease
AU2024357861A1 (en) 2023-10-12 2026-04-23 Renagade Therapeutics Management Inc. Nickase-retron template-based precision editing system and methods of use

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5322770A (en) 1989-12-22 1994-06-21 Hoffman-Laroche Inc. Reverse transcription with thermostable DNA polymerases - high temperature reverse transcription
US5643758A (en) 1987-03-10 1997-07-01 New England Biolabs, Inc. Production and purification of a protein fused to a binding protein
US5654176A (en) 1987-05-28 1997-08-05 Amrad Corporation Limited Fusion proteins containing glutathione-s-transferase
US5736373A (en) * 1996-09-23 1998-04-07 Becton, Dickinson And Company Thermostable DNA polymerase from Bacillus pallidus
US7001745B1 (en) 1998-09-30 2006-02-21 New England Biolabs, Inc. Intein mediated peptide ligation
US6436677B1 (en) * 2000-03-02 2002-08-20 Promega Corporation Method of reverse transcription
US6627424B1 (en) * 2000-05-26 2003-09-30 Mj Bioworks, Inc. Nucleic acid modifying enzymes
WO2003008454A2 (en) 2001-07-18 2003-01-30 Merck Patent Gmbh Glycoprotein vi fusion proteins
US7670807B2 (en) * 2004-03-10 2010-03-02 East Tennessee State Univ. Research Foundation RNA-dependent DNA polymerase from Geobacillus stearothermophilus
US7935509B2 (en) * 2004-08-13 2011-05-03 New England Biolabs, Inc. Intracellular production of a nuclease

Also Published As

Publication number Publication date
EP2403941B1 (en) 2018-10-03
CN102421791A (zh) 2012-04-18
JP2015193666A (ja) 2015-11-05
EP3415621A1 (en) 2018-12-19
US20160289652A1 (en) 2016-10-06
ZA201107207B (en) 2012-12-27
IL214913A0 (en) 2011-11-30
IL214913A (en) 2017-06-29
US20180340158A1 (en) 2018-11-29
CA2754476A1 (en) 2010-09-10
BRPI1009221A2 (pt) 2016-03-15
US10858636B2 (en) 2020-12-08
WO2010102085A3 (en) 2010-11-18
US10113156B2 (en) 2018-10-30
US20180346890A1 (en) 2018-12-06
JP2012519489A (ja) 2012-08-30
US10150955B2 (en) 2018-12-11
WO2010102085A2 (en) 2010-09-10
WO2010102085A4 (en) 2011-01-06
EP2403941A4 (en) 2012-09-05
AU2010221284B2 (en) 2015-10-01
JP5882064B2 (ja) 2016-03-09
AU2010221284A1 (en) 2011-10-27
EP2403941A2 (en) 2012-01-11
US20120009630A1 (en) 2012-01-12

Similar Documents

Publication Publication Date Title
WO2010102085A3 (en) Stabilized reverse transcriptase fusion proteins
MX2010001490A (es) Acidos nucleicos de enlace sdf-1 y uso de los mismos.
WO2009120374A3 (en) Methods and compositions for nucleic acid sample preparation
WO2010111686A3 (en) Labeled enzyme compositions, methods & systems
ATE477321T1 (de) Aviäre telomerase reverse transkriptase
WO2009135212A3 (en) Selective 5' ligation tagging of rna
EP4435100A3 (en) Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
MX292528B (es) Beta-xilosidasas tolerantes al acido y termicas, genes que las codifican, organismos relacionados y metodos.
WO2015024017A3 (en) Rna polymerase, methods of purification and methods of use
WO2015157555A8 (en) Import of unnatural or modified nucleoside triphosphates into cells via nucleic acid triphosphate transporters
WO2009152353A3 (en) Reversible nucleosides and nucleotides terminators and their use in dna sequencing
ATE502122T1 (de) Chemisch modifizierte oligonukleotidprimer zur nukleinsäureamplifikation
WO2009045344A3 (en) Error-free amplification of dna for clonal sequencing
EP3461896A3 (en) Methods of transcription activator like effector assembly
WO2011020033A3 (en) Engineered proteins including mutant fibronectin domains
WO2012062810A3 (en) Cell culture medium and process for protein expression, said medium and process comprising a pam inhibitor
WO2012018639A3 (en) Compositions for stabilizing dna, rna and proteins in saliva and other biological samples during shipping and storage at ambient temperatures
WO2010062779A3 (en) Modified dna polymerases
WO2013083264A8 (en) Dna polymerases with improved activity
WO2010134939A3 (en) Mammalian genes involved in infection
WO2008023247A3 (en) Matrix attachment regions (mars) for increasing transcription and uses thereof
WO2013083263A8 (en) Dna polymerases with improved activity
WO2012170907A3 (en) Polymerization of nucleic acids using proteins having low isoelectric points
EA201000273A1 (ru) Белок-предшественник тиопептида, кодирующий его ген и его применение
WO2008095622A3 (de) Sekretierte luziferase mluc7 und deren verwendung

Legal Events

Date Code Title Description
FA Abandonment or withdrawal